Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3979628
Max Phase: Preclinical
Molecular Formula: C52H94N20O10
Molecular Weight: 1159.45
Molecule Type: Small molecule
Associated Items:
ID: ALA3979628
Max Phase: Preclinical
Molecular Formula: C52H94N20O10
Molecular Weight: 1159.45
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(C)=O)C(=O)N[C@H](C(=O)NC(CC1CCCCC1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
Standard InChI: InChI=1S/C52H94N20O10/c1-5-6-17-35(45(77)72-41(30(2)3)48(80)71-39(26-32-15-8-7-9-16-32)46(78)69-38(49(81)82)21-14-25-63-52(58)59)66-43(75)36(19-12-23-61-50(54)55)68-47(79)40(27-33-28-60-29-64-33)70-44(76)37(20-13-24-62-51(56)57)67-42(74)34(65-31(4)73)18-10-11-22-53/h28-30,32,34-41H,5-27,53H2,1-4H3,(H,60,64)(H,65,73)(H,66,75)(H,67,74)(H,68,79)(H,69,78)(H,70,76)(H,71,80)(H,72,77)(H,81,82)(H4,54,55,61)(H4,56,57,62)(H4,58,59,63)/t34-,35-,36-,37-,38-,39?,40-,41-/m0/s1
Standard InChI Key: BOZMNRGZCPXXRF-GCAPNOEVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1159.45 | Molecular Weight (Monoisotopic): 1158.7462 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Judge RA, Zhu H, Upadhyay AK, Bodelle PM, Hutchins CW, Torrent M, Marin VL, Yu W, Vedadi M, Li F, Brown PJ, Pappano WN, Sun C, Petros AM.. (2016) Turning a Substrate Peptide into a Potent Inhibitor for the Histone Methyltransferase SETD8., 7 (12): [PMID:27994746] [10.1021/acsmedchemlett.6b00303] |
Source(1):